+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Pediatric Vaccines Market by Technology (Attenuated Live Viruses, Conjugates, Inactivated Viruses), Vaccine (Monovalent, Multivalent), Indication, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • January 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968566
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pediatric Vaccines Market size was estimated at USD 19.07 billion in 2023, USD 21.26 billion in 2024, and is expected to grow at a CAGR of 11.57% to reach USD 41.06 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pediatric Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pediatric Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Vaccines Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bavarian Nordic A/S, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Indian Immunologicals Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., SINOVAC Biotech Ltd., and Zoetis Inc.

Market Segmentation & Coverage

This research report categorizes the Pediatric Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Attenuated Live Viruses
    • Conjugates
    • Inactivated Viruses
    • Polysaccharides
    • Recombinant
    • Subunits
    • Toxoids
  • Vaccine
    • Monovalent
    • Multivalent
  • Indication
    • Haemophilus Influenzae Type B
    • Hepatitis
    • Human Papillomavirus
    • Measles
    • Meningitis A
    • Mumps
    • Pneumococcal Diseases
    • Polio
    • Rotaviruses
    • Rubella
    • Tetanus
    • Yellow Fever
  • End User
    • Hospital
    • Pediatric Clinic
    • Research Organization
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Pediatric Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pediatric Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the Pediatric Vaccines Market?
  4. What is the market share of the leading vendors in the Pediatric Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the Pediatric Vaccines Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Frequently Asked Questions about the Global Pediatric Vaccines Market

What is the estimated value of the Global Pediatric Vaccines Market?

The Global Pediatric Vaccines Market was estimated to be valued at $21.26 Billion in 2024.

What is the growth rate of the Global Pediatric Vaccines Market?

The growth rate of the Global Pediatric Vaccines Market is 11.5%, with an estimated value of $41.06 Billion by 2030.

What is the forecasted size of the Global Pediatric Vaccines Market?

The Global Pediatric Vaccines Market is estimated to be worth $41.06 Billion by 2030.

Who are the key companies in the Global Pediatric Vaccines Market?

Key companies in the Global Pediatric Vaccines Market include AstraZeneca PLC, Bavarian Nordic A/S, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Indian Immunologicals Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Chemical Corporation and Novartis AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Pediatric Vaccines Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
5.1.1.3. Government intervention for the use of pediatric vaccines
5.1.2. Restraints
5.1.2.1. Lack of implementation of mandatory vaccination
5.1.2.2. Slight-side effects associated with pediatric vaccines
5.1.3. Opportunities
5.1.3.1. Strong late-stage pipeline and new drug approvals
5.1.3.2. Routinized vaccines used in immunization of infants and children
5.1.4. Challenges
5.1.4.1. No uniform recall or reminder system and staff shortages
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Pediatric Vaccines Market, by Technology
6.1. Introduction
6.2. Attenuated Live Viruses
6.3. Conjugates
6.4. Inactivated Viruses
6.5. Polysaccharides
6.6. Recombinant
6.7. Subunits
6.8. Toxoids
7. Pediatric Vaccines Market, by Vaccine
7.1. Introduction
7.2. Monovalent
7.3. Multivalent
8. Pediatric Vaccines Market, by Indication
8.1. Introduction
8.2. Haemophilus Influenzae Type B
8.3. Hepatitis
8.4. Human Papillomavirus
8.5. Measles
8.6. Meningitis A
8.7. Mumps
8.8. Pneumococcal Diseases
8.9. Polio
8.10. Rotaviruses
8.11. Rubella
8.12. Tetanus
8.13. Yellow Fever
9. Pediatric Vaccines Market, by End User
9.1. Introduction
9.2. Hospital
9.3. Pediatric Clinic
9.4. Research Organization
10. Americas Pediatric Vaccines Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pediatric Vaccines Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pediatric Vaccines Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AstraZeneca PLC
14.1.2. Bavarian Nordic A/S
14.1.3. CSL Limited
14.1.4. Eli Lilly and Company
14.1.5. GlaxoSmithKline PLC
14.1.6. Indian Immunologicals Ltd.
14.1.7. Johnson & Johnson Services, Inc.
14.1.8. Merck & Co., Inc.
14.1.9. Mitsubishi Chemical Corporation
14.1.10. Novartis AG
14.1.11. Pfizer Inc.
14.1.12. Sanofi S.A.
14.1.13. Serum Institute of India Pvt. Ltd.
14.1.14. SINOVAC Biotech Ltd.
14.1.15. Zoetis Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. PEDIATRIC VACCINES MARKET RESEARCH PROCESS
FIGURE 2. PEDIATRIC VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PEDIATRIC VACCINES MARKET DYNAMICS
FIGURE 7. PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2023 VS 2030 (%)
FIGURE 10. PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PEDIATRIC VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 14. PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS , BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. CANADA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CANADA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 48. CANADA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CHINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. CHINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 70. CHINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. CHINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. INDIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. INDIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 74. INDIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 98. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 102. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 106. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 110. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 119. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 123. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 127. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 135. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 139. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. ITALY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. ITALY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 143. ITALY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. ITALY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 151. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 152. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 155. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. POLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. POLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 159. POLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. POLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. QATAR PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. QATAR PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 163. QATAR PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. QATAR PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 179. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 187. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 188. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 191. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 192. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 202. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 203. PEDIATRIC VACCINES MARKET LICENSE & PRICING

Companies Mentioned

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • CSL Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Indian Immunologicals Ltd.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mitsubishi Chemical Corporation
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • SINOVAC Biotech Ltd.
  • Zoetis Inc.

Methodology

Loading
LOADING...